Main Menu
Menu

News

Publish Date
The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows
IPWatchdog
Joe Allen
Proposed ‘price’ criteria for march-in rights poses threat to U.S. innovation, critics say
Tech Transfer Central
Technology Transfer Tactics
Witnesses Clash Over Potential Pros and Cons of PERA in Senate IP Subcommittee Hearing
IPWatchdog
Eileen McDermott
AI adds urgency to patent debate
Axios
Ashley Gold
Special council works to protect and promote STEM excellence
Fox 2 Detroit
Amy Andrews
#27 Jamie Simpson | The U.S. policy perspective on SEPs
The SEP Couch with Tim Pohlmann
The SEP Couch with Tim Pohlmann
Apple Keeps Chasing the Ultimate Health-Tracking Watch—but It Could Take Years
The Wall Street Journal
Aaron Tilley
The Top U.S. FRAND / RAND Licensing Developments of 2023 Part II: Ghosts of Christmas Past and Christmas Future
IPWatchdog
Curtis Dodd and Chris Dubuc
From AI to Amgen, Here’s Everything IP that Mattered in 2023
IPWatchdog
Eileen McDermott
Gov. Hochul expected to veto N.Y. ban on noncompete agreements
New York Daily News
Tim Balk
Why the Apple Watch is being banned — and how Apple can avoid it
The Verge
Victoria Song
How to avoid fake products when shopping online
NBC 6 South Florida
Yaima Crespo
Scroll to Top